Dr. Audina M Berrocal MD
Practice: Bascom Palmer Eye Institute
Location: Miami, FL
Website: https://umiamihealth.org/bascom-palmer-eye-institute
Phone: 305-243-2020
Email: HeretoHelp@med.miami.edu
Audina Berrocal, M.D., is a pediatric retina specialist and world-leader in the medical and surgical management of retinopathy of prematurity and pediatric vitreoretinal disorders. Berrocal has been instrumental in the description and management of pediatric retinal disorders. She has advanced the use of fluorescein angiography in pediatric vitreoretinal disorders improving outcomes. She has also taken care of an inner-city neonatal Intensive Care Unit weekly for the past 20 years preventing blindness among the premature. Furthermore, she has been the first surgeon to treat the youngest patient in the United States with the first FDA-approved gene therapy. She has continued this novel, curative surgical treatment among children with Leber?s congenital amaurosis. Not only is she a unique clinician and outstanding surgeon, but she devotes time to teaching and the support of women in the field of ophthalmology and retina. Dr. Berrocal was named to the Ophthalmologist Power List 2022.
Certifications: Ophthalmology & American Board of Ophthalmology
-
Bascom Palmer Eye Institute
Fellowship, Vitreoretinal Diseases & Surgery, 2002
New England Eye Center - Tufts University
Residency, Ophthalmology, 2000
St Vincent's Hospital & Medical Center
Internship, Rotating, 1997
St Vincent's Hospital & Medical Center
Residency, Rotating, 1997
Tufts University School of Medicine
Medical School, 1996
-
Professor of Clinical Ophthalmology
Secondary Appointment in the Department of Pediatrics
Specialties
Pediatric Retina and Vitreous Diseases
Retina and Vitreous Diseases
Clinical Area
Retinopathy of Prematurity, Macular HolesEpiretinal Membranes, Age-related Macular Degeneration. Diabetic Retinopathy, Pediatric and Adult Retinal Detachments, Vitreoretinal Diseases and Surgery, Pediatric Medical and Surgical Retina, Gene-therapy
-
Age-related macular degeneration
Familial exudative
Retinopathy of prematurity
Incontinentia pigmenti
Retinitis pigmentosa
FAQ
At the Jack McGovern Coats’ Disease Foundation, we are often contacted by anxious parents or patients who are seeking information after receiving a diagnosis of Coats’ Disease. The questions below are provided as a resource to assist you as you and your doctor decide the best approach for treatment. These questions do not constitute any form of medical advice or diagnosis. Each patient is unique. An experienced retinal specialist who has examined the patient is the best source of information for diagnosis and treatment. We always recommend getting a second opinion.
-
Ahead of any treatments or procedures, it is important to ask yourself and the doctor the following questions:
How do you know that this is Coats’ Disease?
Has your doctor treated other patients with Coats’ Disease?
Have you sought a second opinion? If not, please consult our Doctor Directory for knowledgeable doctors in your area.
-
What Stage of Coats’ Disease is he/she in?
Will his/her vision get worse over time?
Will the eye have pain?
Will his/her eye start to turn out? Is muscle corrective surgery an option?
Are cataracts likely?
How likely is glaucoma? (due to retinal detachment)
Is there calcification?
What is the anticipated disease progression?
-
Is there a thorough vision exam available?
Where is the vision affected? (central/peripheral/distance)
Does he/she have depth perception? (3D visibility)
What about the non-Coats’ eye?
To what extent is his/her vision affected?
Will we be able to use this as a baseline to measure progress/decline?
Find a Doctor
Are you a Doctor?
Contact us to learn more about taking the White Coats to Cure Coats pledge today.